Pazopanib-related tumor lysis syndrome in metastatic clear cell renal cell carcinoma: a case report

Investigational New Drugs
Michael W van KalleveenMathijs P Hendriks

Abstract

Introduction Tumor lysis syndrome (TLS) is a life-threatening emergency caused by rapid cell death as a result of anti-tumor therapy. In the era of targeted therapy it has increasingly been observed in solid malignancies such as hepatocellular carcinoma (HCC) and renal cell carcinoma (RCC). Case We describe the case of a 58-year old man with the medical history of a memorial sloan kettering cancer centre (MSKCC) poor prognosis metastasized clear cell renal cell carcinoma (mRCC) who developed TLS within six days after initiating therapy with the tyrosine kinase inhibitor (TKI) pazopanib. Discussion The pharmacokinetics and pharmacodynamics of pazopanib are complex and characterized by a non-linear and time-dependent bioavailability. Pazopanib is almost completely bound to serum albumin (>99.9%). In this presented case, a low serum albumin (26 g/L) might have led to a higher free fraction of pazopanib, which could have resulted in more toxicity. Also, pazopanib is metabolised by the CYP3A4 isoform of the cytochrome P450 group. Low quantities of this enzyme may lead to an impaired and prolonged breakdown of the drug. Conclusion As far as we know this is the first report on pazopanib induced TLS. We advise further research in order...Continue Reading

References

Aug 1, 1981·Clinical Pharmacology and Therapeutics·C A NaranjoD J Greenblatt
May 21, 2003·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Anna Westlind-JohnssonMagnus Ingelman-Sundberg
Apr 6, 2004·The American Journal of Medicine·Michael B DavidsonMartin J Schreiber
May 10, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ganapathy KrishnanAnas Al-Janadi
Jun 11, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Herbert I HurwitzLini Pandite
Jun 24, 2009·Investigational New Drugs·Judith MichelsBernard Escudier
May 13, 2011·The New England Journal of Medicine·Scott C HowardChing-Hon Pui
Apr 19, 2012·Clinical Pharmacology and Therapeutics·Kathrin KleinUlrich M Zanger
Feb 28, 2013·Frontiers in Genetics·Kathrin Klein, Ulrich M Zanger
May 3, 2013·Cancer Chemotherapy and Pharmacology·Antoinette R TanJoseph J Stephenson
Aug 29, 2013·Indian Journal of Anaesthesia·Satyen Parida
Feb 12, 2017·Clinical Pharmacokinetics·Remy B VerheijenNeeltje Steeghs

❮ Previous
Next ❯

Citations

Nov 28, 2019·British Journal of Haematology·Urshila Durani, William J Hogan

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adenocarcinoma, Clear Cell

Clear Cell Adenocarcinoma is a tumor that arises in the female genital tract and is characterized by cells that appear clear under the microscope. Discover the latest research here.